These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33025235)

  • 1. Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome.
    Fujinaga S; Nishino T; Urushihara Y
    Clin Exp Nephrol; 2021 Feb; 25(2):213-214. PubMed ID: 33025235
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.
    Fujinaga S; Hirano D; Murakami H; Ohtomo Y; Shimizu T; Kaneko K
    Pediatr Nephrol; 2012 Apr; 27(4):671-4. PubMed ID: 22198072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
    Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
    Hamasaki Y; Yoshikawa N; Nakazato H; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Ito S; Kaneko T; Honda M;
    Pediatr Nephrol; 2013 May; 28(5):765-71. PubMed ID: 23314441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
    Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
    Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
    Fujinaga S; Hirano D; Nishizaki N; Kamei K; Ito S; Ohtomo Y; Shimizu T; Kaneko K
    Pediatr Nephrol; 2010 Mar; 25(3):539-44. PubMed ID: 20049616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
    Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
    Fujinaga S; Hirano D; Nishizaki N; Someya T; Ohtomo Y; Ohtsuka Y; Shimizu T; Kaneko K
    Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
    Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F
    Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimal change nephrotic syndrome].
    Hirayama K; Kobayashi M
    Nihon Jinzo Gakkai Shi; 2010; 52(7):882-7. PubMed ID: 21077335
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.
    Dorresteijn EM; Kist-van Holthe JE; Levtchenko EN; Nauta J; Hop WC; van der Heijden AJ
    Pediatr Nephrol; 2008 Nov; 23(11):2013-20. PubMed ID: 18622632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
    Katsuno T; Masuda T; Saito S; Kato N; Ishimoto T; Kato S; Kosugi T; Tsuboi N; Kitamura H; Tsuzuki T; Ito Y; Maruyama S
    Clin Exp Nephrol; 2019 Feb; 23(2):207-214. PubMed ID: 30121802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panniculitis associated with steroid use.
    Bagga A; Sethi SK; Sharma A
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):539-41. PubMed ID: 20427888
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
    Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M
    Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR.
    Inoue M; Yumura W; Morishita Y; Ito C; Hamano Y; Ando Y; Muto S; Kusano E
    Clin Nephrol; 2013 Feb; 79(2):101-6. PubMed ID: 22948120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.